These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9725540

  • 1. The relevance of T-type calcium antagonists: a profile of mibefradil.
    Glasser SP.
    J Clin Pharmacol; 1998 Aug; 38(8):659-69. PubMed ID: 9725540
    [Abstract] [Full Text] [Related]

  • 2. Potential cardioprotective effect of mibefradil in the long-term treatment of hypertension.
    Waeber B.
    Cardiology; 1998 Aug; 89 Suppl 1():16-22. PubMed ID: 9570425
    [Abstract] [Full Text] [Related]

  • 3. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN, Markham A.
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [Abstract] [Full Text] [Related]

  • 4. Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists.
    Hermsmeyer K, Mishra S, Miyagawa K, Minshall R.
    Clin Ther; 1997 Nov; 19 Suppl A():18-26. PubMed ID: 9385502
    [Abstract] [Full Text] [Related]

  • 5. Mibefradil: a selective T-type calcium antagonist.
    Massie BM.
    Am J Cardiol; 1997 Nov 06; 80(9A):23I-32I. PubMed ID: 9375939
    [Abstract] [Full Text] [Related]

  • 6. Mibefradil: a new class of calcium-channel antagonists.
    Billups SJ, Carter BL.
    Ann Pharmacother; 1998 Jun 06; 32(6):659-71. PubMed ID: 9640486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mibefradil, a pharmacologically distinct calcium antagonist.
    Ernst ME, Kelly MW.
    Pharmacotherapy; 1998 Jun 06; 18(3):463-85. PubMed ID: 9620098
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Steady-state trough plasma mibefradil concentrations and correlation to blood pressure response in hypertensive patients with chronic renal disease.
    Pordy R, Woittiez A.
    Int J Clin Pharmacol Res; 1998 Jun 06; 18(3):105-8. PubMed ID: 9825266
    [Abstract] [Full Text] [Related]

  • 13. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
    Massie BM.
    Am J Hypertens; 1998 Apr 06; 11(4 Pt 3):95S-102S. PubMed ID: 9607373
    [Abstract] [Full Text] [Related]

  • 14. Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats.
    Vacher E, Richer C, Fornes P, Clozel JP, Giudicelli.
    J Cardiovasc Pharmacol; 1996 May 06; 27(5):686-94. PubMed ID: 8859939
    [Abstract] [Full Text] [Related]

  • 15. The antihypertensive efficacy of the novel calcium antagonist mibefradil in comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension.
    Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Dalle Ave S, Ward C, Lindberg E.
    Am J Hypertens; 1997 Feb 06; 10(2):189-96. PubMed ID: 9037327
    [Abstract] [Full Text] [Related]

  • 16. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects.
    Welker HA.
    J Pharm Pharmacol; 1998 Sep 06; 50(9):983-7. PubMed ID: 9811158
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.
    Clozel JP, Ertel EA, Ertel SI.
    J Hypertens Suppl; 1997 Dec 06; 15(5):S17-25. PubMed ID: 9481612
    [Abstract] [Full Text] [Related]

  • 19. Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.
    Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel JP, Koen R, Macé B, Thuillez C.
    J Am Coll Cardiol; 1997 Feb 06; 29(2):416-21. PubMed ID: 9014998
    [Abstract] [Full Text] [Related]

  • 20. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I, Bieska G, Charlon V, Lindberg E, Pordy R.
    Cardiology; 1998 Feb 06; 89 Suppl 1():23-32. PubMed ID: 9570426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.